Genprex, Inc. (GNPX)

Nasdaq · Pharmaceutical Preparations · Inc. TX

What they're doing

Between 2026-06-14 and 2026-09-12, public records show 1 signal for Genprex, Inc.. Most notable: 2026-06-18: Filed 8-K disclosing director or officer change. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-12 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing director or officer change
  2. Material 8-K filing
    Filed 8-K disclosing material agreement
  3. Material 8-K filing
    Filed 8-K disclosing material agreement

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-04-14LONGNECKER BRENT MdirectorS81.23$10
2026-04-14LONGNECKER BRENT MdirectorS101.23$12
2026-02-27Berger Mark StanleyofficerF7,1682$14,336
2026-02-27Confer Ryan M.directorF9,3302$18,660
2025-12-22Moreno Toscano Jose AntoniodirectorA9,0000$0
2025-12-22Berger Mark StanleyofficerA28,5000$0
2025-12-22Confer Ryan M.directorA45,0000$0
2025-12-22LONGNECKER BRENT MdirectorA9,0000$0
2025-12-22Wilson William R Jr.directorA9,0000$0
2025-06-30Berger Mark StanleyofficerF4,5000.23$1,035
2025-06-30Confer Ryan M.directorF5,7750.23$1,328
2025-02-18Berger Mark StanleyofficerF5850.41$240
2025-02-18Confer Ryan M.directorF3950.41$162
2024-12-05Moreno Toscano Jose AntoniodirectorA4,7500$0
2024-12-05Wilson William R Jr.directorA4,7500$0
2024-12-05LONGNECKER BRENT MdirectorA4,7500$0
2024-12-05Confer Ryan M.directorA29,3750$0
2024-12-05Berger Mark StanleyofficerA18,2500$0

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings